# Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women

> **NCT07184827** · PHASE3 · RECRUITING · sponsor: **TCM Biotech International Corp.** · enrollment: 348 (estimated)

## Conditions studied

- Recurrent Urinary Tract Infections in Women

## Interventions

- **DRUG:** U101
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07184827
- **Lead sponsor:** TCM Biotech International Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-14
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-07-31
- **Target enrollment:** 348 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07184827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07184827, "Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07184827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*